Black Diamond Therapeutics BDTX
NASDAQ BDTX
$2.11 +0.04 (+1.93%)
As of: Oct 21, 2026 · 1:35 PM EDT

Black Diamond Therapeutics (BDTX) FCF Margin (2025)

Updated

Black Diamond Therapeutics (BDTX) reported FCF Margin of 42.31% for FY2025.

Analysis

Black Diamond Therapeutics (BDTX) FCF Margin (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Eli Lilly 1,134.17 Bn 1,102.76 Bn 19.71 Bn 33.76%
2 Johnson & Johnson 615.84 Bn 534.36 Bn 17.26 Bn 28.82%
3 AbbVie 500.69 Bn 473.80 Bn 12.70 Bn 18.33%
4 Merck 367.34 Bn 321.72 Bn 12.21 Bn 26.96%
5 Novartis Ag 297.61 Bn 261.60 Bn 11.24 Bn 38.60%
6 Astrazeneca 261.07 Bn 234.75 Bn 12.86 Bn 6.55%
7 Amgen 235.51 Bn 190.91 Bn 7.24 Bn 34.70%
8 Gilead Sciences 190.60 Bn 164.80 Bn 6.22 Bn 44.00%
9 Pfizer 169.37 Bn 116.02 Bn 10.94 Bn 2.01%
10 Black Diamond Therapeutics 121.04 Mn -371.87 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 76.30%
API Access

Black Diamond Therapeutics FCF Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=fcf-margin&ticker=BDTX&period=max&api_key=YOUR_API_KEY